Page de résultat 2 pour Industrie : Fabricants de médicaments - Général Marché boursier - Cotations et cours
Liste de toutes les actions et titres avec cours, capitalisations boursières, ratios P/E et BPA
Tous les pays
- {{country.name}}
- Tous les pays
- États-Unis (50)
- Argentine (13)
- Australie (1)
- L'Autriche (13)
- Brésil (14)
- Canada (2)
- Chili (4)
- Chine (22)
- Finlande (2)
- France (3)
- Allemagne (58)
- Hong Kong (4)
- Hongrie (1)
- Inde (20)
- Indonésie (1)
- Italie (5)
- Japon (9)
- Mexique (14)
- Singapour (1)
- Corée du Sud (3)
- Espagne (1)
- Suède (3)
- Suisse (6)
- Taïwan (1)
- Turquie (1)
- Royaume-Uni (20)
Tous marchés
- {{item.name}}
- Tous marchés
- ASX (1)
- BSE (10)
- Budapest (1)
- Buenos Aires (13)
- Canadian Sec (1)
- Cboe CA (1)
- Frankfurt (45)
- Helsinki (2)
- HKSE (4)
- IOB (17)
- Istanbul (1)
- Jakarta (1)
- KSE (3)
- LSE (3)
- MCE (1)
- Mexico (14)
- Milan (5)
- Munich (1)
- NasdaqCM (1)
- NasdaqGM (1)
- NasdaqGS (6)
- NSE (10)
- NYSE (9)
- OTC Markets OTCPK (30)
- OTC Markets OTCQX (3)
- Paris (3)
- Santiago (4)
- São Paulo (14)
- SES (1)
- Shanghai (11)
- Shenzhen (11)
- Stockholm (3)
- Swiss (6)
- Taipei Exchange (1)
- Tokyo (9)
- Vienna (13)
- XETRA (12)
Tous secteur
- {{item.name}}
- Tous secteur
- Soins de santé (279)
Fabricants de médicaments - Général (279)
- {{item.name}}
- Toutes les industries
- Apports Agricoles (323)
- Matériaux de construction (471)
- Produits chimiques (605)
- Produits chimiques spécialisés (1353)
- Production de bois de charpente et du bois (160)
- Papiers et produits en papier (269)
- Aluminium (141)
- Cuivre (216)
- Autres métaux industriels et mines (2765)
- Or (1700)
- Argent (84)
- Autres métaux précieux et mines (660)
- Charbon à coke (71)
- Acier (744)
- Concessionnaires automobiles et de camions (212)
- Fabricants d'automobiles (388)
- Pièces d'automobiles (1166)
- Véhicules de plaisance (85)
- Ameublement, équipements et appareils électroménagers (507)
- Construction Résidentielle (214)
- Fabrication de textiles (520)
- Fabrication de vêtements (444)
- Chaussures et Accessoires (208)
- Emballage et Conteneurs (481)
- Services Personnels (140)
- Restaurants (539)
- Vêtements au détail (289)
- Grands Magasins (276)
- Aménagement intérieur - commerce de détail (106)
- Produits de luxe (260)
- Vente au détail sur Internet (408)
- Vente au détail de spécialité (547)
- Jeux d'argent (205)
- Loisirs (411)
- Logement (321)
- Station de Loisirs et casinos (188)
- Services de voyage (192)
- Gestion d'actifs (1966)
- Banques - Diversifiées (308)
- Banques - Régionales (2297)
- Financement hypothécaire (171)
- Marchés des Capitaux (888)
- Données financières et bourses (151)
- Assurance - Vie (260)
- Assurance - IARD (270)
- Assurance - Réassurance (74)
- Assurance - Spécialité (72)
- Courtiers d'assurances (67)
- Assurance - diversifié (306)
- Sociétés écrans (1820)
- Conglomérats financiers (100)
- Services de Crédit (660)
- Immobilier - Développement (966)
- Services Immobiliers (1145)
- Immobilier - Diversifié (316)
- FPI - Soins médicaux (64)
- FPI - Hôtel et Motel (86)
- FPI - Industriel (141)
- FPI - Bureau (169)
- FPI - Résidentiel (108)
- FPI - Vente au détail (230)
- FPI - Hypothèque (130)
- FPI - Spécialité (83)
- FPI - Diversifié (332)
- Boissons - Brasseurs (162)
- Boissons - Vignobles et Distilleries (242)
- Boissons - Non Alcoolisées (217)
- Confiseurs (170)
- Produits agricoles (610)
- Produits domestiques et personnels (523)
- Aliments emballés (1270)
- Services d'éducation et de formation (305)
- Magasins d'escompte (97)
- Distribution alimentaire (210)
- Epiceries (233)
- Tabac (105)
- Biotechnologie (2611)
- Fabricants de médicaments - Général (279)
- Fabricants de médicaments - de spécialité et génériques (1705)
- Plans de soins de santé (57)
- Établissements de soins médicaux (553)
- Détaillants Pharmaceutiques (155)
- Services d'information sur la santé (419)
- Dispositifs médicaux (913)
- Instruments médicaux et des fournitures (501)
- Diagnostiques et Recherche (427)
- Distribution médicale (138)
- Services publics - Producteurs indépendants d'électricité (170)
- Services publics - Renouvelables (561)
- Services publics - Eau réglementée (173)
- Services Publics - produits électriques réglementés (468)
- Services publics - Gaz réglementé (205)
- Services publics - diversifiés (214)
- Services de Télécommunication (910)
- Agences de Publicité (508)
- Publication (259)
- Diffusion (213)
- Divertissement (679)
- Contenu d'internet et information (530)
- Jeux électroniques et multimédia (484)
- Forage pétrolier et gazier (80)
- Exploration et Production du Pétrole et Gaz (1185)
- Pétrole et Gaz Intégrés (246)
- Pétrole et Gaz-Midstream (230)
- Pétrole et Gaz - Raffinage et Marketing (278)
- Service et l'équipement du pétrole et Gaz (480)
- Charbon thermique (229)
- Uranium (140)
- Aérospatial et Défense (560)
- Services aux entreprises spécialisées (640)
- Services d’experts-conseils (195)
- Services de location (219)
- Services de sécurité et de protection (267)
- Services de dotation en personnel et d’emploi (252)
- Conglomérats (723)
- Ingénierie et Construction (1492)
- Opérations d'infrastructure (156)
- Produits de construction et équipement (513)
- Machinerie agricole et de construction lourde (376)
- Distribution industrielle (235)
- Équipement et fournitures d’entreprise (142)
- Machines Industries spécialisées (1720)
- Fabrication de métal (393)
- Les contrôles de la pollution et de traitement (265)
- Outils et accessoires (240)
- Équipement et pièces électriques (897)
- Aéroports et services aériens (135)
- Compagnies aériennes (229)
- Chemins de fer (260)
- Transport maritime (505)
- Camionnage (99)
- Fret et logistique intégrés (388)
- Gestion des déchets (354)
- Services des technologies de l'information (1178)
- Logiciel - Application (2113)
- Logiciel - Infrastructure (955)
- Matériel de communication (731)
- Matériel Informatique (434)
- Produits électroniques à l'usage des consommateurs (282)
- Composants électroniques (971)
- Électronique et distribution informatique (239)
- Instruments scientifiques et techniques (347)
- Equipements et matériaux semi-conducteurs (350)
- Semi-conducteurs (611)
- Solaire (222)
| Nom Nom | Prix Prix |
24h% 7j Graphique 24h%&7j |
Cap. du marché Cap. du marché | VOL Volume | 24h bas | 24h de haut | Cap. du marché | PER | BPA |
|---|
| Nom Nom | Prix Prix |
24h% 7j Graphique 24h%&7j |
Cap. du marché Cap. du marché | VOL Volume | 24h bas | 24h de haut | Cap. du marché | PER | BPA | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Eli Lilly and Company LLYC.VI | $631.8 690.64 USD |
-7.79
|
$567.35B 620.19B USD | $274 299.52 USD | $623.3 681.35 USD | $653.6 714.47 USD | $567.35B 620.19B USD | 58.71 | $10.76 11.76 USD | |
| Johnson & Johnson JNJ.BA | $13,675 16.16 USD |
-2.67
|
$397.49T 469.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $397.49T 469.84B USD | 10.99 | $1.24K 1.47 USD | |
| Johnson & Johnson JNJ.MX | $3,070 181.78 USD |
-5.68
|
$7.4T 438.07B USD | $2.66K 157.21 USD | $3,070 181.78 USD | $3,085.88 182.72 USD | $7.4T 438.07B USD | 26.56 | $115.55 6.84 USD | |
| Johnson & Johnson JNJB34.SA | $58.42 11.84 USD |
-2.09
|
$2.11T 428.02B USD | $2.16K 438 USD | $58 11.76 USD | $59.66 12.09 USD | $2.11T 428.02B USD | 26.92 | $2.17 0.44 USD | |
| AbbVie Inc. ABBV.BA | $24,975 29.52 USD |
0
|
$355.33T 420.02B USD | $395 0.47 USD | $24,025 28.4 USD | $25,400 30.02 USD | $355.33T 420.02B USD | 9.72 | $2.57K 3.03 USD | |
| AbbVie Inc. ABBV.MX | $3,912 231.64 USD |
0
|
$6.92T 409.76B USD | $1 0.06 USD | $3,912 231.64 USD | $3,912 231.64 USD | $6.92T 409.76B USD | 81.96 | $47.73 2.83 USD | |
| Johnson & Johnson JNJ.SN | $148.27 — |
0
|
$396.76B — | $0 — | $145.55 — | $145.55 — | $396.76B — | 22.43 | $6.61 — | |
| AbbVie Inc. ABBV34.SA | $67.5 13.68 USD |
-0.28
|
$1.91T 387.23B USD | $1.72K 348.21 USD | $65.52 13.28 USD | $67.75 13.73 USD | $1.91T 387.23B USD | 80.35 | $0.84 0.17 USD | |
| Johnson & Johnson JNJ.F | $137.66 150.48 USD |
-2.15
|
$331.74B 362.64B USD | $2.42K 2.65K USD | $133.5 145.93 USD | $139.9 152.93 USD | $331.74B 362.64B USD | 26.22 | $5.25 5.74 USD | |
| Johnson & Johnson JNJ.VI | $136.58 149.3 USD |
-3.68
|
$329.14B 359.79B USD | $980 1.07K USD | $134.82 147.38 USD | $138.9 151.84 USD | $329.14B 359.79B USD | 25.76 | $5.3 5.79 USD | |
| AbbVie Inc. 4AB.F | $169.6 185.4 USD |
-1.95
|
$300.02B 327.96B USD | $2.46K 2.69K USD | $156 170.53 USD | $169.6 185.4 USD | $300.02B 327.96B USD | 78.51 | $2.16 2.36 USD | |
| AbbVie Inc. ABBV.VI | $167.4 182.99 USD |
-5.28
|
$296.13B 323.71B USD | $0 0 USD | $161.6 176.65 USD | $167.4 182.99 USD | $296.13B 323.71B USD | 76.43 | $2.19 2.39 USD | |
| AbbVie Inc. 4AB.DE | $165.8 181.24 USD |
-6.09
|
$293.3B 320.61B USD | $6.76K 7.39K USD | $156 170.53 USD | $172 188.02 USD | $293.3B 320.61B USD | 76.40 | $2.17 2.37 USD | |
| Roche Holding AG ROGN.MX | $6,280.1 371.86 USD |
0
|
$4.87T 288.48B USD | $0 0 USD | $6,280.1 371.86 USD | $6,280.1 371.86 USD | $4.87T 288.48B USD | 26.24 | $239.27 14.17 USD | |
| Merck & Co., Inc. MRK.PA | $101.4 110.84 USD |
0
|
$260.61B 284.88B USD | $250 273.28 USD | $100.2 109.53 USD | $101.6 111.06 USD | $260.61B 284.88B USD | 21.03 | $4.82 5.27 USD | |
| AstraZeneca PLC AZNN.MX | $1,490 88.23 USD |
0
|
$4.62T 273.53B USD | $1 0.06 USD | $1,490 88.23 USD | $1,490 88.23 USD | $4.62T 273.53B USD | 33.22 | $44.85 2.66 USD | |
| AstraZeneca PLC AZN.BA | $44,525 52.63 USD |
-2.68
|
$229.28T 271.01B USD | $975 1.15 USD | $43,625 51.57 USD | $45,150 53.37 USD | $229.28T 271.01B USD | 9.20 | $4.84K 5.72 USD | |
| Novartis AG NVS.BA | $35,425 41.87 USD |
0
|
$227.25T 268.62B USD | $0 0 USD | $35,425 41.87 USD | $35,425 41.87 USD | $227.25T 268.62B USD | 2.80 | $12.61K 14.91 USD | |
| Merck & Co., Inc. MRK.BA | $21,950 25.95 USD |
+0.69
|
$222.63T 263.16B USD | $718 0.85 USD | $21,300 25.18 USD | $22,400 26.48 USD | $222.63T 263.16B USD | 0.30 | $72.42K 85.6 USD | |
| Novartis AG NVSN.MX | $2,235 132.34 USD |
0
|
$4.41T 261.38B USD | $0 0 USD | $2,235 132.34 USD | $2,235 132.34 USD | $4.41T 261.38B USD | 19.08 | $117.11 6.93 USD | |
| Novartis AG N1VS34.SA | $62.73 12.71 USD |
0
|
$1.24T 251.12B USD | $0 0 USD | $62.73 12.71 USD | $62.73 12.71 USD | $1.24T 251.12B USD | 18.95 | $3.31 0.67 USD | |
| Merck & Co., Inc. MRK.MX | $1,672.01 99 USD |
-0.65
|
$4.22T 250.09B USD | $18 1.07 USD | $1,670 98.88 USD | $1,672.01 99 USD | $4.22T 250.09B USD | 12.43 | $134.47 7.96 USD | |
| Merck & Co., Inc. MRCK34.SA | $60.09 12.18 USD |
-3.08
|
$1.21T 246.12B USD | $2.07K 420.37 USD | $58.38 11.83 USD | $61.98 12.56 USD | $1.21T 246.12B USD | 12.65 | $4.75 0.96 USD | |
| Roche Holding AG RHHBF | $336.92 — |
+3.67
|
$244.3B — | $50 — | $325 — | $330.5 — | $244.3B — | 28.64 | $11.76 — | |
| Merck & Co., Inc. MRK.SN | $96.42 — |
-25.14
|
$243.56B — | $0 — | $96.42 — | $96.42 — | $243.56B — | 14.30 | $6.74 — | |
| AstraZeneca PLC A1ZN34.SA | $63.5 12.87 USD |
-5.39
|
$1.18T 239.42B USD | $155 31.42 USD | $63.42 12.85 USD | $65.76 13.33 USD | $1.18T 239.42B USD | 30.09 | $2.11 0.43 USD | |
| Roche Holding AG RHHVF | $294 — |
-3.45
|
$237.83B — | $100 — | $294 — | $294 — | $237.83B — | 25.02 | $11.75 — | |
| Pfizer Inc. PFE.ST | $422.6 41.25 USD |
0
|
$2.42T 235.74B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.42T 235.74B USD | 0 | $0 0 USD | |
| AstraZeneca PLC AZNCF | $136.64 — |
-1.02
|
$230.37B — | $100 — | $138.05 — | $138.05 — | $230.37B — | 30.36 | $4.5 — | |
| Roche Holding AG RHO6.F | $32.41 35.43 USD |
-6.25
|
$207.4B 226.72B USD | $60 65.59 USD | $32.41 35.43 USD | $32.82 35.87 USD | $207.4B 226.72B USD | 23.83 | $1.36 1.49 USD | |
| AstraZeneca PLC ZEGA.F | $59 64.49 USD |
-4.84
|
$201.03B 219.75B USD | $100 109.31 USD | $59 64.49 USD | $59.5 65.04 USD | $201.03B 219.75B USD | 28.92 | $2.04 2.23 USD | |
| AstraZeneca PLC ZEG.F | $119.9 131.07 USD |
-5.14
|
$200.39B 219.05B USD | $4.46K 4.88K USD | $118.65 129.7 USD | $121 132.27 USD | $200.39B 219.05B USD | 29.45 | $4.07 4.45 USD | |
| Amgen Inc. AMGN.MX | $6,430 380.73 USD |
0
|
$3.45T 204.53B USD | $0 0 USD | $6,430 380.73 USD | $6,430 380.73 USD | $3.45T 204.53B USD | 42.73 | $150.46 8.91 USD | |
| Merck & Co., Inc. MRK.VI | $73.9 80.78 USD |
-2.38
|
$186.67B 204.06B USD | $1.33K 1.45K USD | $72.4 79.14 USD | $73.9 80.78 USD | $186.67B 204.06B USD | 11.95 | $6.18 6.76 USD | |
| Amgen Inc. AMGN.BA | $13,100 15.48 USD |
+0.19
|
$170.24T 201.23B USD | $259 0.31 USD | $12,750 15.07 USD | $13,200 15.6 USD | $170.24T 201.23B USD | 0.32 | $40.61K 48.01 USD | |
| Merck & Co., Inc. 6MK.F | $72.8 79.58 USD |
-2.02
|
$183.9B 201.02B USD | $369 403.37 USD | $72.7 79.47 USD | $73.4 80.24 USD | $183.9B 201.02B USD | 11.93 | $6.1 6.67 USD | |
| Novartis AG NOTA.F | $92.2 100.79 USD |
-5.73
|
$182.1B 199.06B USD | $11 12.02 USD | $92 100.57 USD | $92.2 100.79 USD | $182.1B 199.06B USD | 17.33 | $5.32 5.82 USD | |
| Amgen Inc. AMGN34.SA | $60.06 12.17 USD |
-2.88
|
$903.4B 183.11B USD | $1.22K 246.87 USD | $59.85 12.13 USD | $60.06 12.17 USD | $903.4B 183.11B USD | 39.51 | $1.52 0.31 USD | |
| Gilead Sciences, Inc. GILD.BA | $35,775 42.29 USD |
-3.31
|
$143.65T 169.8B USD | $0 0 USD | $0 0 USD | $0 0 USD | $143.65T 169.8B USD | 87.71 | $407.84 0.48 USD | |
| Gilead Sciences, Inc. GILD.MX | $2,259.6 133.8 USD |
0
|
$2.82T 166.79B USD | $1 0.06 USD | $2,259.6 133.8 USD | $2,259.6 133.8 USD | $2.82T 166.79B USD | 294.21 | $7.68 0.45 USD | |
| Pfizer Inc. PFE.BA | $7,720 9.13 USD |
+0.39
|
$140.51T 166.09B USD | $3.84K 4.53 USD | $7,340 8.68 USD | $7,740 9.15 USD | $140.51T 166.09B USD | 2.54 | $3.03K 3.58 USD | |
| Pfizer Inc. PFE.MX | $470.9 27.88 USD |
<0.01
|
$2.67T 158.14B USD | $195 11.55 USD | $468.55 27.74 USD | $470.9 27.88 USD | $2.67T 158.14B USD | 16.75 | $28.11 1.66 USD | |
| Gilead Sciences, Inc. GILD34.SA | $312.05 63.25 USD |
-2.09
|
$778.02B 157.69B USD | $3 0.61 USD | $312.05 63.25 USD | $312.05 63.25 USD | $778.02B 157.69B USD | 288.93 | $1.08 0.22 USD | |
| Amgen Inc. AMGN.VI | $265.95 290.72 USD |
-3.34
|
$142.87B 156.18B USD | $1.58K 1.73K USD | $251.45 274.87 USD | $269.65 294.76 USD | $142.87B 156.18B USD | 38.37 | $6.93 7.58 USD | |
| Amgen Inc. AMG.DE | $261.15 285.47 USD |
-5.14
|
$140.29B 153.36B USD | $3.98K 4.35K USD | $250 273.28 USD | $268.6 293.62 USD | $140.29B 153.36B USD | 38.12 | $6.85 7.49 USD | |
| Pfizer Inc. PFIZ34.SA | $33 6.69 USD |
-1.87
|
$748.63B 151.74B USD | $7K 1.42K USD | $32.19 6.52 USD | $33.73 6.84 USD | $748.63B 151.74B USD | 16.66 | $1.98 0.4 USD | |
| Amgen Inc. AMG.F | $255 278.75 USD |
-8.27
|
$136.99B 149.75B USD | $255 278.75 USD | $254 277.66 USD | $255 278.75 USD | $136.99B 149.75B USD | 37.28 | $6.84 7.48 USD | |
| Pfizer Inc. PFE.SN | $26.06 — |
0
|
$147.8B — | $0 — | $26.06 — | $26.06 — | $147.8B — | 18.48 | $1.41 — | |
| Gilead Sciences, Inc. GILD.SN | $95.78 — |
+6.77
|
$142.75B — | $0 — | $95.78 — | $95.78 — | $142.75B — | 252.05 | $0.38 — | |
| Bristol-Myers Squibb Company BMY.BA | $24,300 28.72 USD |
-1.52
|
$119.06T 140.73B USD | $2.69K 3.18 USD | $23,925 28.28 USD | $24,450 28.9 USD | $119.06T 140.73B USD | 0 | -$4,737 -5.6 USD | |
| Gilead Sciences, Inc. GIS.F | $98.08 107.21 USD |
-0.93
|
$122.27B 133.66B USD | $1.57K 1.72K USD | $92.31 100.91 USD | $98.08 107.21 USD | $122.27B 133.66B USD | 280.22 | $0.35 0.38 USD | |
| Bristol-Myers Squibb Company BMY.MX | $1,105 65.43 USD |
-2.04
|
$2.25T 133.13B USD | $139 8.23 USD | $1,105 65.43 USD | $1,105 65.43 USD | $2.25T 133.13B USD | 0 | -$87.98 -5.2 USD | |
| Sanofi SNW.F | $93.28 101.97 USD |
-0.24
|
$121.49B 132.8B USD | $2.15K 2.35K USD | $86 94.01 USD | $93.28 101.97 USD | $121.49B 132.8B USD | 21.24 | $4.39 4.8 USD | |
| Sanofi SNYNF | $103.98 — |
-5.34
|
$132.79B — | $100 — | $103.98 — | $103.98 — | $132.79B — | 21.43 | $4.85 — | |
| Sanofi SANF.MI | $96.82 105.84 USD |
0
|
$121.24B 132.54B USD | $0 0 USD | $0 0 USD | $0 0 USD | $121.24B 132.54B USD | 0 | $0 0 USD | |
| Gilead Sciences, Inc. GILD.VI | $96.43 105.41 USD |
-4.98
|
$120.21B 131.41B USD | $694 758.64 USD | $92.9 101.55 USD | $97.1 106.14 USD | $120.21B 131.41B USD | 275.51 | $0.35 0.38 USD | |
| Gilead Sciences, Inc. GIS.DE | $95.78 104.7 USD |
-5.56
|
$119.4B 130.52B USD | $16.1K 17.6K USD | $90.73 99.18 USD | $97.85 106.96 USD | $119.4B 130.52B USD | 281.70 | $0.34 0.37 USD | |
| Bristol-Myers Squibb Company BMYB34.SA | $316.18 64.08 USD |
-1.84
|
$643.35B 130.4B USD | $13 2.63 USD | $313.62 63.57 USD | $316.18 64.08 USD | $643.35B 130.4B USD | 0 | -$24.82 -5.03 USD | |
| Pfizer Inc. PFE.VI | $20.59 22.51 USD |
-3.42
|
$116.78B 127.65B USD | $7.83K 8.55K USD | $19.9 21.75 USD | $20.6 22.52 USD | $116.78B 127.65B USD | 15.96 | $1.29 1.41 USD | |
| Sanofi SANO.VI | $93.29 101.98 USD |
-4.53
|
$116.25B 127.08B USD | $826 902.93 USD | $91.21 99.7 USD | $93.77 102.5 USD | $116.25B 127.08B USD | 21.25 | $4.39 4.8 USD | |
| Sanofi SNW2.F | $47 51.38 USD |
-5.24
|
$115.39B 126.14B USD | $100 109.31 USD | $47 51.38 USD | $47 51.38 USD | $115.39B 126.14B USD | 21.36 | $2.2 2.4 USD | |
| Pfizer Inc. PFEB.F | $6.5 7.11 USD |
-5.8
|
$111.13B 121.48B USD | $209 228.47 USD | $6.3 6.89 USD | $6.5 7.11 USD | $111.13B 121.48B USD | 15.11 | $0.43 0.47 USD | |
| GSK plc GSK.BA | $12,175 14.39 USD |
-5.44
|
$98.9T 116.9B USD | $0 0 USD | $0 0 USD | $0 0 USD | $98.9T 116.9B USD | 27.85 | $437.08 0.52 USD | |
| Bristol-Myers Squibb Company BRM.DE | $49.7 54.33 USD |
-2.72
|
$101.13B 110.55B USD | $3.82K 4.18K USD | $47.01 51.38 USD | $49.75 54.38 USD | $101.13B 110.55B USD | 0 | -$4 -4.3 USD | |
| Bristol-Myers Squibb Company BMYS.VI | $49.4 54 USD |
-3.17
|
$100.51B 109.87B USD | $0 0 USD | $47.64 52.07 USD | $49.52 54.13 USD | $100.51B 109.87B USD | 0 | -$4.05 -4.4 USD | |
| Bristol-Myers Squibb Company BRM.F | $48.38 52.89 USD |
-4.05
|
$98.44B 107.61B USD | $81 88.54 USD | $47.9 52.36 USD | $48.38 52.89 USD | $98.44B 107.61B USD | 0 | -$3.99 -4.3 USD | |
| Gilead Sciences, Inc. GILD.MI | $72.4 79.14 USD |
0
|
$90.19B 98.59B USD | $0 0 USD | $0 0 USD | $0 0 USD | $90.19B 98.59B USD | 0 | $0 0 USD | |
| GSK plc GSKN.MX | $811 48.02 USD |
0
|
$1.65T 97.52B USD | $0 0 USD | $811 48.02 USD | $811 48.02 USD | $1.65T 97.52B USD | 25.00 | $32.44 1.92 USD | |
| GSK GLAXF | $20.12 — |
0
|
$85B — | $107 — | $20.12 — | $20.16 — | $85B — | 24.83 | $0.81 — | |
| GSK plc G1SK34.SA | $41.08 8.33 USD |
-5
|
$417.11B 84.54B USD | $6 1.22 USD | $41.08 8.33 USD | $42 8.51 USD | $417.11B 84.54B USD | 22.44 | $1.83 0.37 USD | |
| Chugai Pharmaceutical Co., Ltd. CUP.F | $38.61 42.21 USD |
-1.91
|
$66.5B 72.69B USD | $30 32.79 USD | $38.06 41.6 USD | $41 44.82 USD | $66.5B 72.69B USD | 26.44 | $1.46 1.6 USD | |
| Bayer Aktiengesellschaft BAY.MI | $55.5 60.67 USD |
0
|
$55.21B 60.36B USD | $0 0 USD | $0 0 USD | $0 0 USD | $55.21B 60.36B USD | 0 | $0 0 USD | |
| Daiichi Sankyo Company, Limited D4S.F | $20.12 21.99 USD |
-9.9
|
$37.75B 41.26B USD | $2K 2.19K USD | $20.12 21.99 USD | $20.12 21.99 USD | $37.75B 41.26B USD | 25.15 | $0.8 0.87 USD | |
| Otsuka Holdings Co., Ltd. OS1.F | $43.8 47.88 USD |
-6.41
|
$23.66B 25.87B USD | $420 459.12 USD | $43.8 47.88 USD | $43.8 47.88 USD | $23.66B 25.87B USD | 11.17 | $3.92 4.29 USD | |
| Biogen Inc. BIIB.MX | $2,854 168.99 USD |
0
|
$417.75B 24.74B USD | $0 0 USD | $2,854 168.99 USD | $2,854 168.99 USD | $417.75B 24.74B USD | 12.80 | $222.9 13.2 USD | |
| Biogen Inc. BIIB.BA | $12,600 14.89 USD |
-0.98
|
$19.15T 22.64B USD | $119 0.14 USD | $12,225 14.45 USD | $12,600 14.89 USD | $19.15T 22.64B USD | 1.04 | $12.01K 14.2 USD | |
| Biogen Inc. BIIB34.SA | $122.52 24.83 USD |
0
|
$108.04B 21.9B USD | $0 0 USD | $122.52 24.83 USD | $122.52 24.83 USD | $108.04B 21.9B USD | 11.72 | $10.45 2.12 USD | |
| Bayer Aktiengesellschaft BAYER.BD | $8,000 22.13 USD |
-2.03
|
$7.86T 21.74B USD | $135 0.37 USD | $7,500 20.74 USD | $8,000 22.13 USD | $7.86T 21.74B USD | 0 | -$1,043.6 -2.8 USD | |
| Bayer Aktiengesellschaft BAYN.VI | $19.69 21.52 USD |
-1.91
|
$19.36B 21.17B USD | $20.58K 22.49K USD | $18.66 20.4 USD | $19.75 21.59 USD | $19.36B 21.17B USD | 0 | -$2.6 -2.8 USD | |
| Bayer Aktiengesellschaft BAYA.F | $4.8 5.25 USD |
-2.04
|
$19.34B 21.14B USD | $1K 1.09K USD | $4.54 4.96 USD | $4.8 5.25 USD | $19.34B 21.14B USD | 0 | -$0.65 -0.7 USD | |
| Biogen Inc. BIIB.VI | $109 119.15 USD |
-4.76
|
$15.95B 17.44B USD | $216 236.12 USD | $108.15 118.22 USD | $111.7 122.1 USD | $15.95B 17.44B USD | 10.63 | $10.25 11.2 USD | |
| Biogen Inc. IDP.DE | $108.95 119.1 USD |
-4.47
|
$15.95B 17.43B USD | $307 335.59 USD | $106.3 116.2 USD | $110.85 121.17 USD | $15.95B 17.43B USD | 10.75 | $10.13 11.07 USD | |
| Biogen Inc. IDP.F | $107 116.97 USD |
-5.93
|
$15.66B 17.12B USD | $20 21.86 USD | $107 116.97 USD | $107 116.97 USD | $15.66B 17.12B USD | 10.57 | $10.12 11.06 USD | |
| Astellas Pharma Inc. YPH.F | $7.75 8.47 USD |
-3.41
|
$14.88B 16.27B USD | $27 29.51 USD | $7.75 8.47 USD | $7.75 8.47 USD | $14.88B 16.27B USD | 0 | -$0.2 -0.2 USD | |
| Astellas Pharma ALPMF | $9 — |
-4.76
|
$16.2B — | $108 — | $9 — | $9 — | $16.2B — | 0 | -$0.22 — | |
| Astellas Pharma Inc. YPHA.F | $7.7 8.42 USD |
-7.78
|
$14.21B 15.53B USD | $0 0 USD | $7.7 8.42 USD | $7.7 8.42 USD | $14.21B 15.53B USD | 0 | -$0.2 -0.2 USD | |
| Cipla Limited CIPLA.BO | $1,384.4 16.75 USD |
-2.2
|
$1.12T 13.53B USD | $127.21K 1.54K USD | $1,310.05 15.85 USD | $1,401.1 16.95 USD | $1.12T 13.53B USD | 22.43 | $61.72 0.75 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. RER1.F | $46.64 50.98 USD |
-8.1
|
$9.72B 10.63B USD | $5 5.47 USD | $46.64 50.98 USD | $48.1 52.58 USD | $9.72B 10.63B USD | 23.43 | $1.99 2.18 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. REC.VI | $46.64 50.98 USD |
-8.64
|
$9.66B 10.56B USD | $0 0 USD | $46.64 50.98 USD | $47.96 52.43 USD | $9.66B 10.56B USD | 23.43 | $1.99 2.18 USD | |
| Orion Oyj ORINY | $31.1 — |
+0.13
|
$8.18B — | $248 — | $31.06 — | $31.06 — | $8.18B — | 24.29 | $1.28 — | |
| CSPC Pharmaceutical CHJTF | $0.56 — |
-13.85
|
$8.11B — | $11K — | $0.93 — | $0.9499 — | $8.11B — | 11.19 | $0.05 — | |
| Orion Oyj OFK.F | $50.75 55.48 USD |
-1.8
|
$7.27B 7.95B USD | $66 72.15 USD | $50.75 55.48 USD | $50.75 55.48 USD | $7.27B 7.95B USD | 21.59 | $2.35 2.57 USD | |
| Kyowa Kirin KYKOF | $14.75 — |
0
|
$7.89B — | $316 — | $14.75 — | $14.75 — | $7.89B — | 19.40 | $0.76 — | |
| Kyowa Kirin Co., Ltd. KY4.F | $12.6 13.77 USD |
-3.12
|
$6.92B 7.57B USD | $254 277.66 USD | $12.3 13.45 USD | $12.6 13.77 USD | $6.92B 7.57B USD | 18.00 | $0.7 0.77 USD | |
| Orion Oyj OFK0.F | $24.8 27.11 USD |
-7.46
|
$6.85B 7.49B USD | $0 0 USD | $24.8 27.11 USD | $24.8 27.11 USD | $6.85B 7.49B USD | 21.19 | $1.17 1.28 USD | |
| Abbott India Limited ABBOTINDIA.NS | $28,965.7 350.44 USD |
-0.38
|
$615.5B 7.45B USD | $14.09K 170.42 USD | $27,500.05 332.7 USD | $29,400.05 355.69 USD | $615.5B 7.45B USD | 46.11 | $628.07 7.6 USD | |
| Abbott India Limited ABBOTINDIA.BO | $28,927.9 349.98 USD |
-0.42
|
$614.7B 7.44B USD | $544 6.58 USD | $27,598.55 333.9 USD | $29,299.95 354.48 USD | $614.7B 7.44B USD | 46.10 | $627.46 7.59 USD | |
| CSPC Pharmaceutical Group Limited CVG.F | $0.54 0.59 USD |
-14.63
|
$6.29B 6.87B USD | $1K 1.09K USD | $0.52 0.56 USD | $0.54 0.59 USD | $6.29B 6.87B USD | 10.71 | $0.05 0.05 USD | |
| Orion Oyj ORINF | $43.02 — |
0
|
$6.75B — | $43 — | $47.16 — | $47.16 — | $6.75B — | 17.41 | $2.47 — | |
| CSPC Pharmaceutical Group Limited CVGU.F | $1.85 2.02 USD |
-21.61
|
$5.77B 6.31B USD | $250 273.28 USD | $1.85 2.02 USD | $1.85 2.02 USD | $5.77B 6.31B USD | 10.27 | $0.18 0.2 USD | |
|
Aucune action favorite
Vous n'avez pas encore d'actions favorites, veuillez l'ajouter aux favoris pour la voir ici |
||||||||||
- {{ link.label }} {{link}}